| Literature DB >> 34052134 |
J-P Gérard1, N Barbet2, C Dejean3, L Montagne3, K Bénézery3, R Coquard2, J Doyen3, J Durand Labrunie4, J-M Hannoun-Lévi3.
Abstract
The Papillon experience and the Lyon R96-02 trial have shown that contact X-ray brachytherapy of 50kV is efficient and safe to achieve long term local control and organ preservation for cT1 and early cT2-3 rectal cancers. The OPERA trial, using the Papillon 50™ machine, brings further support to this preservation strategy for selected T2T3ab lesions. Future trials using a contact X-ray boost will try to consolidate and enlarge its place in organ preservation for rectal cancers.Entities:
Keywords: Cancer du rectum; Contact X-ray brachytherapy; Curiethérapie par rayons X de contact; Organ preservation; Papillon technique; Préservation des organes; Rectal cancer; Technique Papillon
Mesh：
Year: 2021 PMID： 34052134 DOI： 10.1016/j.canrad.2021.04.006
Source DB: PubMed Journal: Cancer Radiother ISSN： 1278-3218 Impact factor: 1.018